Selective inhibition of heme oxygenase-2 activity by analogs of 1-(4-chlorobenzyl)-2-(pyrrolidin-1-ylmethyl)-1H-benzimidazole (clemizole): Exploration of the effects of substituents at the N-1 position.
Jason Z Vlahakis, Dragic Vukomanovic, Kanji Nakatsu, Walter A Szarek
Index: Bioorg. Med. Chem. 21(21) , 6788-95, (2013)
Full Text: HTML
Abstract
Several analogs based on the lead structure of 1-(4-chlorobenzyl)-2-(pyrrolidin-1-ylmethyl)-1H-benzimidazole (clemizole) were synthesized and evaluated as novel inhibitors of heme oxygenase (HO). Many of the compounds were found to be potent and highly selective for the HO-2 isozyme (constitutive), and had substantially less inhibitory activity on the HO-1 isozyme (inducible). The compounds represent the first report of highly potent and selective inhibitors of HO-2 activity, and complement our suite of selective HO-1 inhibitors. The study has revealed many candidates based on the inhibition of heme oxygenases for potentially useful pharmacological and therapeutic applications. Copyright © 2013 Elsevier Ltd. All rights reserved.
Related Compounds
Related Articles:
Selective inactivation of monoamine oxidase B by aminoethyl 3-chlorobenzyl ether. Ding CZ and Silverman RB.
[Bioorg. Med. Chem. 3(10) , 2077-2078, (1993)]
Convenient and robust one-pot synthesis of symmetrical and unsymmetrical benzyl thioethers from benzyl halides using thiourea. Eccles KS, et al.
[ARKIVOC ix , 216-218, (2010)]